Important News & Announcements

Stay up to date with the latest news and announcements from NASCSA.

Back to all news

DEA Releases Updated Prescriber Manual

Posted 7/13/2023

On June 14, 2023, DEA posted its newly revised Practitioner?s Manual on its Diversion website. A copy of the guide is attached to this email for your convenience. The manual is current and includes the recent elimination of the requirement for a special registration to treat opioid use disorder (DATA-Waiver).'s_Manual_(final).pdf

The 2023 edition replaces all previous versions of the Practitioner?s Manual issued by DEA, both hard copy and electronic.

Back to all news

Sponsor Spotlight

COMPASS Pathways

COMPASS Pathways is delighted to be a sponsor of NASCSA and looks forward to both engaging with controlled substances authorities, NASCSA leadership, and members to learn about their important work, and educate about our company's mission and the innovations underway using novel therapies.

COMPASS Pathways is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. Our focus is on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments.

We are developing innovative therapies and, when appropriate, combining them with psychological support and next-generation digital tools to forge new, sustainable mental health care pathways.

Our investigational COMP360 psilocybin therapy is currently undergoing phase 3 investigation in treatment-resistant depression. We are also assessing COMP360 in anorexia nervosa and post-traumatic stress disorder, across multiple clinical studies.

Learn more

All Sponsors